June 2, 2020 / 9:56 AM / a month ago

BRIEF-Dr. Lal Pathlabs Says Adverse Impact Of Lockdown On Co's Revenue Seen Until Q2 FY21

June 2 (Reuters) - Dr. Lal PathLabs Ltd:

* ADVERSE IMPACT OF LOCKDOWNS/RESTRICTIONS ON CO’S REVENUE EXPECTED TO CONTINUE UNTIL Q2 FY21

* REVENUE FROM COVID-19 TESTING ONLY CONTRIBUTING TO RECOVERY OF FIXED AND VARIABLE COSTS INCURRED BY CO FOR SUCH TESTS

* REVENUE FROM COVID-19 TESTING NOT EXPECTED TO BE ACCRETIVE TO BOTTOM LINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below